What is the effect of verapamil on mortality and major events after acute myocardial infarction?
The effect of verapamil on mortality and major events after acute myocardial infarction was studied in the Danish Verapamil Infarction Trial II (DAVIT II). The results of this trial showed that treatment with verapamil resulted in a significant reduction in mortality and major events after acute myocardial infarction compared to placebo. Additionally, the results of this trial showed that verapamil was more effective at reducing mortality and major events after acute myocardial infarction in patients with a history of systemic hypertension than in those without a history of systemic hypertension.  